Palisade Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $500 | $0 | $0 | $0 |
Gross Profit | 500 | |||
EBITDA | -10,574 | -9,601 | -10,182 | -2,862 |
EBIT | -10,182 | -2,863 | ||
Net Income | -10,574 | -9,600 | -8,899 | -2,868 |
Net Change In Cash | 500 | 0 | 0 | 0 |
Free Cash Flow | -7,603 | -3,890 | -3,144 | -3,553 |
Cash | 125,172 | 132,628 | 133,385 | 5,227 |
Basic Shares | 211,381 | 209,663 | 55,669 | 7,473 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $250 | $250 |
Gross Profit | -3 | -3 | 250 | -167 |
EBITDA | -16,768 | -14,423 | -12,281 | -14,244 |
EBIT | -16,771 | -14,426 | -12,285 | -14,247 |
Net Income | -16,781 | -14,438 | -12,300 | -14,260 |
Net Change In Cash | 0 | 0 | 250 | 250 |
Free Cash Flow | -10,847 | -12,193 | -11,137 | -13,370 |
Cash | 133,385 | 9,821 | 12,432 | 12,383 |
Basic Shares | 55,669 | 1,416 | 456 | 880 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.05 |
2026-03-31 | -$0.04 |
2025-12-31 | -$0.05 |
2025-09-30 | -$0.38 |